Schedule 13G ownership disclosure

TONIX PHARMACEUTICALS HOLDIN

Security class unavailable · CUSIP: 890260706

Event date: 2020-02-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,242,515
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-020861
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
Feb 14, 2020
Reporting period
Feb 07, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub